A citation-based method for searching scientific literature

Natchaya Vanwong, Nattawat Ngamsamut, Sadeep Medhasi, Apichaya Puangpetch, Montri Chamnanphon, Teerarat Tan-Kam, Yaowaluck Hongkaew, Penkhae Limsila, Chonlaphat Sukasem. J Child Adolesc Psychopharmacol 2017
Times Cited: 19







List of co-cited articles
119 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study.
Ilan Youngster, Ditza A Zachor, Lidia V Gabis, Adina Bar-Chaim, Patricia Benveniste-Levkovitz, Malka Britzi, Stefan Soback, Tomer Ziv-Baran, Matitiahu Berkovitch. Dev Med Child Neurol 2014
30
52

Effect of CYP2D6, CYP3A5, and MDR1 genetic polymorphisms on the pharmacokinetics of risperidone and its active moiety.
Qian Xiang, Xia Zhao, Ying Zhou, Jing Li Duan, Yi Min Cui. J Clin Pharmacol 2010
63
42

Detection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levels.
Natchaya Vanwong, Nattawat Ngamsamut, Yaowaluck Hongkaew, Nopphadol Nuntamool, Apichaya Puangpetch, Montri Chamnanphon, Ananya Sinrachatanant, Penkhae Limsila, Chonlaphat Sukasem. Drug Metab Pharmacokinet 2016
20
42

The effect of the Taq1A variant in the dopamine D₂ receptor gene and common CYP2D6 alleles on prolactin levels in risperidone-treated boys.
Yvette Roke, Peter N van Harten, Barbara Franke, Tessel E Galesloot, Annemieke M Boot, Jan K Buitelaar. Pharmacogenet Genomics 2013
27
42

Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
C T Correia, J P Almeida, P E Santos, A F Sequeira, C E Marques, T S Miguel, R L Abreu, G G Oliveira, A M Vicente. Pharmacogenomics J 2010
59
36

Prolactin release in children treated with risperidone: impact and role of CYP2D6 metabolism.
Pieter W Troost, Bertine E Lahuis, Mirjam H Hermans, Jan K Buitelaar, Herman van Engeland, Lawrence Scahill, Ruud B Minderaa, Pieter J Hoekstra. J Clin Psychopharmacol 2007
47
36

Impact of Pharmacogenetic Markers of CYP2D6 and DRD2 on Prolactin Response in Risperidone-Treated Thai Children and Adolescents With Autism Spectrum Disorders.
Chonlaphat Sukasem, Yaowaluck Hongkaew, Nattawat Ngamsamut, Apichaya Puangpetch, Natchaya Vanwong, Montri Chamnanphon, Bhunnada Chamkrachchangpada, Ananya Sinrachatanant, Penkhae Limsila. J Clin Psychopharmacol 2016
24
36

9-Hydroxyrisperidone-Induced Hyperprolactinaemia in Thai Children and Adolescents with Autism Spectrum Disorder.
Nattawat Ngamsamut, Yaowaluck Hongkaew, Natchaya Vanwong, Pornpen Srisawasdi, Apichaya Puangpetch, Bhunnada Chamkrachangpada, Theerarat Tan-Khum, Penkhae Limsila, Chonlaphat Sukasem. Basic Clin Pharmacol Toxicol 2016
16
37

Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
Teresa Cabaleiro, Dolores Ochoa, Rosario López-Rodríguez, Manuel Román, Jesús Novalbos, Carmen Ayuso, Francisco Abad-Santos. Hum Psychopharmacol 2014
26
31

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone.
Nikolina Jovanović, Nada Božina, Mila Lovrić, Vesna Medved, Miro Jakovljević, Alma Mihaljević Peleš. Eur J Clin Pharmacol 2010
65
31

The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation.
Jose de Leon, Margaret T Susce, Run-Mei Pan, Maureen Fairchild, Walter H Koch, Peter J Wedlund. J Clin Psychiatry 2005
226
31

Complexities of CYP2D6 gene analysis and interpretation.
Andrea Gaedigk. Int Rev Psychiatry 2013
138
26

Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers.
Jesús Novalbos, Rosario López-Rodríguez, Manuel Román, Sonia Gallego-Sandín, Dolores Ochoa, Francisco Abad-Santos. J Clin Psychopharmacol 2010
49
26

CYP2D6 polymorphisms and their influence on risperidone treatment.
Apichaya Puangpetch, Natchaya Vanwong, Nopphadol Nuntamool, Yaowaluck Hongkaew, Monpat Chamnanphon, Chonlaphat Sukasem. Pharmgenomics Pers Med 2016
28
26

Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
Chadi Albert Calarge, Del D Miller. J Child Adolesc Psychopharmacol 2011
24
26

Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10.
Hee-Doo Yoo, Sang-No Lee, Hyun-Ah Kang, Hea-Young Cho, Il-Kwon Lee, Yong-Bok Lee. Br J Pharmacol 2011
32
21


Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
J K Hicks, J J Swen, C F Thorn, K Sangkuhl, E D Kharasch, V L Ellingrod, T C Skaar, D J Müller, A Gaedigk, J C Stingl. Clin Pharmacol Ther 2013
281
21

The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.
A Gaedigk, S D Simon, R E Pearce, L D Bradford, M J Kennedy, J S Leeder. Clin Pharmacol Ther 2008
510
21

Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6 genotype.
Laura Alexandra Nussbaum, Victor Dumitraşcu, Anca Tudor, Raluca Grădinaru, Nicoleta Andreescu, Maria Puiu. Rom J Morphol Embryol 2014
15
26

Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4.
J Fang, M Bourin, G B Baker. Naunyn Schmiedebergs Arch Pharmacol 1999
192
21

Hyperprolactinemia in Children and Adolescents with Use of Risperidone: Clinical and Molecular Genetics Aspects.
Amilton dos Santos Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Adriana Perez Ferreira Neto, Lúcia Arisaka Paes, Osmar Henrique Della Torre, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra Júnior,[...]. J Child Adolesc Psychopharmacol 2015
18
22

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone.
M G Scordo, E Spina, G Facciolà, A Avenoso, I Johansson, M L Dahl. Psychopharmacology (Berl) 1999
159
21

Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.
Natchaya Vanwong, Santirat Prommas, Apichaya Puangpetch, Yaowaluck Hongkaew, Nopadol Nuntamool, Chalitpol Na Nakorn, Nattawat Ngamsamut, Penkhae Limsila, Chonlaphat Sukasem. J Clin Lab Anal 2016
10
40

Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.
Pieter J Hoekstra, Pieter W Troost, Bertine E Lahuis, Hans Mulder, Erik J Mulder, Barbara Franke, Jan K Buitelaar, George M Anderson, Lawrence Scahill, Ruud B Minderaa. J Child Adolesc Psychopharmacol 2010
35
21

Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents.
Amilton Dos Santos-Júnior, Taciane Barbosa Henriques, Maricilda Palandi de Mello, Osmar Henrique Della Torre, Lúcia Arisaka Paes, Adriana Perez Ferreira-Neto, Letícia Esposito Sewaybricker, Thiago Salum Fontana, Eloisa Helena Rubello Valler Celeri, Gil Guerra-Júnior,[...]. Int J Endocrinol 2016
11
36

Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients.
Sadeep Medhasi, Darawan Pinthong, Ekawat Pasomsub, Natchaya Vanwong, Nattawat Ngamsamut, Apichaya Puangpetch, Monpat Chamnanphon, Yaowaluck Hongkaew, Jirawat Pratoomwun, Penkhae Limsila,[...]. Front Pharmacol 2016
10
40

Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents.
Catherine M T Sherwin, Shannon N Saldaña, Robert R Bies, Michael G Aman, Alexander A Vinks. Ther Drug Monit 2012
20
21

Prediction of CYP2D6 phenotype from genotype across world populations.
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl-Carrillo, Teri Klein, J Steven Leeder. Genet Med 2017
244
21

Pharmacogenomics and Efficacy of Risperidone Long-Term Treatment in Thai Autistic Children and Adolescents.
Nopphadol Nuntamool, Nattawat Ngamsamut, Natchaya Vanwong, Apichaya Puangpetch, Monpat Chamnanphon, Yaowaluck Hongkaew, Penkhae Limsila, Chuthamanee Suthisisang, Bob Wilffert, Chonlaphat Sukasem. Basic Clin Pharmacol Toxicol 2017
12
33

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
Kelly E Caudle, Katrin Sangkuhl, Michelle Whirl-Carrillo, Jesse J Swen, Cyrine E Haidar, Teri E Klein, Roseann S Gammal, Mary V Relling, Stuart A Scott, Daniel L Hertz,[...]. Clin Transl Sci 2020
169
21

Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
Rhee-Hun Kang, Sun-Min Jung, Kyoung-Ah Kim, Duk-Ki Lee, Hyun-Kee Cho, Bong-Joo Jung, Young-Ku Kim, Seung-Hyun Kim, Changsu Han, Min-Soo Lee,[...]. J Clin Psychopharmacol 2009
36
15

Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais.
Payiarat Suwannasri, Wanna Thongnoppakhun, Pornpen Pramyothin, Anunchai Assawamakin, Chanin Limwongse. Clin Biochem 2011
18
16


Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort.
Tyren M Dodgen, Arinda Eloff, Connie Mataboge, Louw J L Roos, Werdie C W van Staden, Michael S Pepper. Appl Transl Genom 2015
6
50

Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update.
K R Crews, A Gaedigk, H M Dunnenberger, J S Leeder, T E Klein, K E Caudle, C E Haidar, D D Shen, J T Callaghan, S Sadhasivam,[...]. Clin Pharmacol Ther 2014
397
15

CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
Dana Ravyn, Vipa Ravyn, Robert Lowney, Henry A Nasrallah. Schizophr Res 2013
60
15

Pharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphisms.
Andrea L Cartwright, Kyle J Wilby, Susan Corrigan, Mary H H Ensom. Ann Pharmacother 2013
16
18

Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen.
Montri Chamnanphon, Khunthong Pechatanan, Ekapob Sirachainan, Narumol Trachu, Wasun Chantratita, Ekawat Pasomsub, Wilai Noonpakdee, Insee Sensorn, Chonlaphat Sukasem. Pharmgenomics Pers Med 2013
26
15

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone.
Yaowaluck Hongkaew, Nattawat Ngamsamut, Apichaya Puangpetch, Natchaya Vanwong, Pornpen Srisawasdi, Montri Chamnanphon, Bhunnada Chamkrachchangpada, Teerarat Tan-Kam, Penkhae Limsila, Chonlaphat Sukasem. Neuropsychiatr Dis Treat 2015
14
21

Risperidone-related weight gain: genetic and nongenetic predictors.
Hsien-Yuan Lane, Yi-Ching Liu, Chieh-Liang Huang, Yue-Cune Chang, Po-Lun Wu, Chung-Ta Lu, Wen-Ho Chang. J Clin Psychopharmacol 2006
104
15

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
469
15

Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.
Jeffrey R Bishop, Fedra Najjar, Leah H Rubin, Stephen J Guter, Thomas Owley, Matthew W Mosconi, Suma Jacob, Edwin H Cook. Pharmacogenet Genomics 2015
16
18

Risperidone.
David Germann, Natalie Kurylo, Feixue Han. Profiles Drug Subst Excip Relat Methodol 2012
11
27

Antipsychotic medication prescribing trends in children and adolescents.
Joyce Nolan Harrison, Fallon Cluxton-Keller, Deborah Gross. J Pediatr Health Care 2012
98
15

Age and gender effects on olanzapine and risperidone plasma concentrations in children and adolescents.
Wolfgang Aichhorn, Josef Marksteiner, Thomas Walch, Gerald Zernig, Hartmann Hinterhuber, Christoph Stuppaeck, Georg Kemmler. J Child Adolesc Psychopharmacol 2007
30
15

CYP2D6 genotype analysis of a Thai population: platform comparison.
Monpat Chamnanphon, Andrea Gaedigk, Natchaya Vanwong, Nopphadol Nuntamool, Yaowaluck Hongkaew, Apichaya Puangpetch, Chonlaphat Sukasem. Pharmacogenomics 2018
7
42

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C Hiemke, N Bergemann, H W Clement, A Conca, J Deckert, K Domschke, G Eckermann, K Egberts, M Gerlach, C Greiner,[...]. Pharmacopsychiatry 2018
366
15

Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
Marin M Jukic, Robert L Smith, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. Lancet Psychiatry 2019
49
15

Pharmacogenetics of Risperidone-Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder.
Chonlaphat Sukasem, Natchaya Vanwong, Pornpen Srisawasdi, Nattawat Ngamsamut, Nopphadol Nuntamool, Yaowaluck Hongkaew, Apichaya Puangpetch, Bhunnada Chamkrachangpada, Penkhae Limsila. Basic Clin Pharmacol Toxicol 2018
14
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.